3-in-1 integrated system for inhaled nitric oxide (iNO) generation, delivery, and monitoring1Find out more
Two patented Ionizers™ (main and backup) provide unlimited, on-demand generation of iNO from room air, regardless of dose or flow.
Main, backup, and bagging modes with the flexibility to deliver iNO continuously through both the main Injector Line and Bagging System.
Comprehensive monitoring system with high- and low-priority alarms for comprehensive patient safety.
Power the LungFit PH System on and deliver a preset iNO dose within 1 minute.2
Integrated auto-purging also saves clinician time while reducing the risk of exposing patients to potentially high levels of NO2.3
The only system with patented Ionizer technology that generates
iNO from room air.1 Here’s how it works:
For Illustrative Purposes
*Based on device readiness.
The LungFit PH System is designed by the same inventors who developed the first nitric oxide delivery system and other systems in use worldwide.†
†The inventors of the LungFit Systems are also listed as inventors on the patents for the following nitric oxide delivery systems: INOvent, INOmax DSIR, INOmax DSIR Plus, INOmax DSIR Plus MRI.
‡LungFlex Rapid Replacement Program response times are based on hospital locations. While every effort is made to accommodate emergency deliveries within 6 hours of request, some hospital locations may take longer.
Please contact Beyond Air Medical Information regarding any medical questions: email@example.com
"*" indicates required fields
References: 1. LungFit PH System Operator’s Manual. Garden City, NY: Beyond Air Inc. 2022. 2. Data on file. Beyond Air Inc. 2021. 3. Rimkus M, Bathe D, Montgomery F. On-demand nitric oxide for ventilator-based nitric oxide inhalation: a risk-reduction perspective. Abstracts of International Society for Aerosols in Medicine e.V. 22nd ISAM Congress, May 24, 2019, Montreux, Switzerland. J Aerosol Med Pulm Drug Deliv. 2019;32(3). https://doi.org/10.1089/jamp.2019.ab02.abstracts
The nitric oxide from the LungFit PH System is indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents. Refer to the full Prescribing Information within the LungFit PH System Operator’s Manual before use.
Consult the LungFit PH System Operator’s Manual for complete information. For technical support, call 1-855-586-4359.